PACTR201902822178026已完成未知
A randomized controlled double-blind study comparing dexmedetomidine and esmolol effects on Cardiac recovery in patients undergoing valve replacement surgery.
menoufia university hospitals0 个研究点目标入组 120 人开始时间: 2019年2月12日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19 Year(s) 至 44 Year(s)（—）
- 性别
- All
入选标准
- •patients aged 18-70 years old,
- •ASA I-III,
- •of both sexes
- •undergoing valve replacement surgery
排除标准
- •Patients refused to take part in the study,
- •allergic to esmolol and dexmedetomidine,
- •history of ß-blocker or dexmedetomidine intake,
- •history of cardiac conduction abnormalities
- •and with pericarditis
研究者
相似试验
已完成
3 期
A double-blind randomized controlled trial comparing 0.75mg of Palonosetron with 1mg of Granisetron for the control of highly emetogenic chemotherapy-induced emesis.Malignant tumor (lung cancer,gastric cancer,esophagus cancer,cervical cancer,endometrial cancer,head and neck cancer,etc)JPRN-UMIN000004863Pharma Valley Center,Shizuoka Organization for Creation Industries840
已完成
3 期
A double-blind randomized controlled trial comparing 3mg and 1mg of ranisetron for the control of chemotherapy-induced acute emesisMalignant tumor (breast cancer, lung cancer, gastric cancer, esophagus cancer, colorectal cancer, etc)JPRN-UMIN000000984Pharma Valley Center, Shizuoka Organization for Creation Industries360
已完成
不适用
A double-blind randomized controlled trial comparing PArietene self-fixing semi-Resorbable mesh with standard heavy-weight polypropylene mesh on chronic inguinal pAin DEvelopmentChronic pain after inguinal hernia repair10041297NL-OMON31651Tyco Health Care350
进行中（未招募）
1 期
A clinical study to assess the efficacy of Orelvo (voclosporin) compared with placebo in achieving renal response after 24 weeks of therapy in subjects with active lupus nephritis (LN)upus NephritisMedDRA version: 21.1 Level: PT Classification code 10025140 Term: Lupus nephritis System Organ Class: 10038359 - Renal and urinary disordersEUCTR2016-004045-81-PLAurinia Pharmaceuticals, Inc.324
进行中（未招募）
1 期
A clinical study to assess the efficacy of Orelvo (voclosporin) compared with placebo in achieving renal response after 24 weeks of therapy in subjects with active lupus nephritis (LN)Active Lupus NephritisMedDRA version: 19.1Level: PTClassification code 10025140Term: Lupus nephritisSystem Organ Class: 10038359 - Renal and urinary disordersEUCTR2016-004045-81-ESAurinia Pharmaceuticals, Inc.324